Use of Mammography Down Since 2009 for Breast Cancer Survivors
TUESDAY, April 12, 2022 (HealthDay News) — For breast cancer survivors, the use of mammography has been declining since 2009, according to a study published in the April issue of the Journal of the National Comprehensive Cancer Network.Katherine P. L…
Learn MoreHypertension, CHD Risk Up With History of Allergic Disorders
TUESDAY, April 12, 2022 (HealthDay News) — Adults with a history of allergic disorders have an increased likelihood of hypertension and coronary heart disease (CHD), according to a study presented at ACC ASIA, a joint meeting of the American College …
Learn MorePotential Moral Injury Seen in Health Care Workers Similar to Vets
TUESDAY, April 12, 2022 (HealthDay News) — The potential for moral injury is high among combat veterans and COVID-19 health care workers (HCWs) and is associated with negative mental health outcomes, according to a study published online April 5 in t…
Learn MoreShorter Prophylactic Antibiotics Feasible After Clean Orthopedic Surgery
MONDAY, April 12, 2022 (HealthDay News) — Shorter antimicrobial prophylaxis duration is noninferior in preventing health care-associated infections following clean orthopedic surgery, according to a study published online April 12 in JAMA Network Open.
Kosei Nagata, Ph.D., from the University of Tokyo Hospital, and colleagues examined whether a shorter antimicrobial prophylaxis duration (
The researchers found that health care-associated infections occurred in 4.6 percent of patients discontinued within 24 hours and in 6.6 percent of those discontinued within 48 hours. A risk difference of −1.99 percentage points (95 percent confidence interval, −5.05 to 1.06 percentage points; P
“These findings lend support to the global movement against antimicrobial resistance and provide additional information on adequate antimicrobial prophylaxis for clean orthopedic surgery,” the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Learn MoreFirst Generic of Symbicort Receives FDA Approval
TUESDAY, April 12, 2022 (HealthDay News) — The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenan…
Learn MoreWith COVID, Inflammation May Be Triggering Loss of Smell
TUESDAY, April 12, 2022 (HealthDay News) — Immune system-triggered inflammation is the likely reason for the loss of smell reported by many COVID-19 patients, a new study finds.”As a neuropathologist, I wondered why smell loss is a very common sympto…
Learn MoreLa pandemia está provocando una escasez de trabajadores de cuidados de salud a largo plazo en EE. UU.
LUNES, 11 de abril de 2022 (HealthDay News) — La pandemia ha empeorado una larga escasez de personal en los hogares de ancianos y otros centros de cuidados a largo plazo de EE. UU. Ahora, un nuevo estudio muestra que unas tasas altas de rotación de e…
Learn MoreIndicios de que una innovadora terapia de células T con RAQ podría combatir a los cánceres de tumores sólidos
LUNES, 11 de abril de 2022 (HealthDay News) — Una terapia basada en el sistema inmunitario que ha resultado efectiva contra los cánceres de la sangre también podría ser útil para luchar contra los cánceres de tumores sólidos, muestran los datos inici…
Learn More